Device brand name · Implantable infusion pump

Infusaid Implantable Infusion Pump: medical device reports filed with FDA

192 reports name it, 1996–1997. Manufacturer given most often on reports: Strato/Infusaid.

Read first · FDA's statement on these data

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product. openFDA, FDA

FDA adds: "Although MDRs are a valuable source of information, this passive surveillance system has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data. In addition, the incidence or prevalence of an event cannot be determined from this reporting system alone due to potential under-reporting of events and lack of information about frequency of device use." And: "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices."

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

192
device reports naming the brand: 0% of all MAUDE reports · about 6 a year; 0
reports, 12 months to August 2026: 0 in the 12 months before; 2.6%
classified as malfunction: 62.3% across all reports; 3.1%
classified as death, as reported: 6 reports · not verified by FDA

FDA's MAUDE database holds 192 reports that name the brand "Infusaid Implantable Infusion Pump" (implantable infusion pump), received between January 1996 and August 1997; the manufacturer given most often on reports is Strato/Infusaid. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (93.8%), death (3.1%) and malfunction (2.6%). Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are output, low (20.3%), reaction (16.1%) and explanted (9.9%). The patient problems coded most often are pain, swelling and seroma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Infusaid Implantable Infusion Pump was received in the five years to August 2026; the latest was received in August 1997.

Event type and report source

Event type, as classified on the report

Death3.1%6

Injury93.8%180

Malfunction2.6%5

Other0.5%1

Not given0%0

Who filed the report

Manufacturer report99.5%191

Voluntary report0%0

User facility report0%0

Distributor report0%0

Not given0.5%1

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)	Reports	Share
Output, low	39	20.3%
Reactiona reaction, type not specified	31	16.1%
Explanted	19	9.9%
Output, high	19	9.9%
Occlusion within devicethe device blocked	14	7.3%
Other (for use when an appropriate device code cannot be identified)	13	6.8%
Difficult to insertthe device was hard to insert	12	6.3%
Leak/splashthe device leaked	9	4.7%
Device remains implanted	7	3.6%
Migration or expulsion of device	7	3.6%
Dislodged	6	3.1%
Implant, removal of	5	2.6%
Malfunction	3	1.6%
Material erosion	3	1.6%
No device output	3	1.6%
Application program problem: dose calculation error	2	1%
Device inoperablethe device could not be used	2	1%
Device issuea problem with the device	2	1%
Displacement	2	1%
Inaccurate delivery	2	1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)	Reports	Share
Painpain, site not specified	31	16.1%
Swellingswelling	13	6.8%
Seromaa collection of fluid under the skin	7	3.6%
Therapeutic response, decreased	6	3.1%
Deaththe patient died; cause not stated by this term	5	2.6%
Hematomaa collection of blood under the skin or in tissue	5	2.6%
Bleeding	4	2.1%
Complaint, ill-defined	4	2.1%
Overdosea dose above the recommended amount	4	2.1%
Vomitingbeing sick	4	2.1%
Inadequate pain relief	3	1.6%
Reactiona reaction, type not specified	3	1.6%
Allergic reactionan allergic reaction	2	1%
Burning sensationa burning feeling	2	1%
Discomfortdiscomfort	2	1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

Measure	Infusaid Implantable Infusion Pump	All MAUDE reports
Reports	192	26,136,888
Share of that pool	—	0%
Classified as death, per 1,000 reports	31	9
Classified as injury	93.8%	36.2%
Classified as malfunction	2.6%	62.3%
Filed by the manufacturer	99.5%	94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Questions about Infusaid Implantable Infusion Pump reports

How many FDA reports name Infusaid Implantable Infusion Pump?

192 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (93.8%), death (3.1%) and malfunction (2.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

output, low (20.3%), reaction (16.1%), explanted (9.9%), output, high (9.9%) and occlusion within device (7.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (99.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Infusaid Implantable Infusion Pump was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.